Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
Matteo Rinaldi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Maddalena Giannella(Hospital General Universitario Gregorio Marañón), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Patrizia Burra(University of Padua), Umberto Cillo(University of Padua), Alberto Ferrarese(University of Padua), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Renato Pascale(University of Bologna), Francesco Cristini, Simone Ambretti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Milo Gatti(University of Bologna), Pierluigi Viale(Azienda USL di Bologna), Erica Franceschini(University of Modena and Reggio Emilia), Simona Coladonato(University of Turin), Russell E. Lewis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Monica Cricca(Azienda Unità Sanitaria Locale Della Romagna), Cristina Mussini(University of Modena and Reggio Emilia), Caterina Campoli(University of Bologna), Maria Cristina Morelli(Azienda Ospedaliero-Universitaria Careggi), Michele Bartoletti(University of Bologna), Sara Tedeschi(University of Bologna)
Cited by 19
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998